Individualizing Management in T2D With CKD

A leading expert provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
Vivian A. Fonseca, MD, FRCP
Format: Microsoft PowerPoint (.ppt)
File Size: 5.80 MB
Released: September 21, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings